Background: The use of antiplatelet therapy in combination with oral anticoagulants remains controversial. The objective of this study was to estimate and compare the incidence of adverse and coronary ...

Munich, Germany - 28 Aug 2018: Combined oral anticoagulant and antiplatelet therapy is associated with a worse prognosis than anticoagulation alone in newly diagnosed atrial fibrillation patients ...

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk ...

NASHVILLE, Tenn. — For prevention of stroke, major bleeding or death, it did not matter whether patients with cervical artery dissection were treated with antiplatelet drugs or anticoagulants, ...

For patients with atrial fibrillation who undergo TAVR, being discharged on antiplatelet therapy seems key in reducing the risk of stroke at 2 years, according to post hoc analysis of PARTNER II data.

Please provide your email address to receive an email when new articles are posted on . The multitarget stool DNA test had a positive predictive value of 31.4% for detecting advanced adenomas.

PHILADELPHIA -- Current anticoagulant or antiplatelet use is not necessarily a contraindication for administering tissue plasminogen activator (tPA) to a stroke patient in the emergency department, a ...

Patients with newly diagnosed atrial fibrillation who take not only an oral anticoagulant (OAC) but also an antiplatelet face increased risks of stroke and bleeding at 1 year, according to an analysis ...

Patients with atrial fibrillation who took oral anticoagulants alone after undergoing transcatheter aortic valve replacement (TAVR) had a lower rate of bleeding complications without an increased risk ...

The use of anticoagulants and antiplatelet agents to treat patients with cardiovascular disease is widespread. Over the past decade, novel anticoagulants including rivaroxaban, apixaban, edoxaban, ...

The population-based study from the U.K. showed that taking an SSRI and OAC (both direct OACs and vitamin K antagonists [VKAs]) together was associated with a 33% increased risk of major bleeding ...

This investigation was conducted at Kaiser Permanente Colorado (KPCO), a group-model, not-for-profit, health maintenance organization providing integrated medical care to approximately 435,000 members ...